This is important since excessive blood glucose levels can cause health complications, such as: Neither Accu-Chek nor its parent company, Roche Diabetes Care, Inc., currently have listings on the ...

Roche announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. This significant milestone paves the way for the solution to be made ...

Right now, it produces approximately 5.2 billion Accu-Chek diabetes test strips annually. Roche says it plans to invest $50 billion in pharmaceuticals and diagnostics in the United States over the ...

In this instance, the partnership will combine Senseonics’ Eversense continuous glucose monitor (CGM), TypeZero’s InControl algorithms, and Roche’s Accu-Chek Insight Insulin Pump.

Roche's Indianapolis campus has established itself as a hub for glucose monitors and diabetes research. The site produces approximately 5.2 billion Accu-Chek diabetes test strips each year and ...

Roche accused manufacturers and sellers based in India of selling counterfeit versions of its Accu-Chek devices, which are used to test blood glucose levels. The company made the claim in a ...